Literature DB >> 2537285

Dietary epidemiology of colon cancer.

V G Vogel1, R S McPherson.   

Abstract

Epidemiologic studies of the relationship of diet to cancer etiology are hampered by methodologic difficulties which can be overcome by careful trial design. The use of appropriate dietary assessment instruments is necessary to minimize bias and improve accuracy of diet assessment. Population studies implicate dietary fat intake in the etiology of colorectal carcinogenesis, and the incidence of colorectal malignancies around the world is positively correlated with meat and fat consumption and total calorie intake. Retrospective studies of fat intake yield equivocal results, whereas prospective studies have failed to show a relationship between fat intake and colon cancer risk. An inverse relationship exists between fiber consumption and colorectal cancer incidence and mortality rates. The positive observational studies are supported by laboratory studies of experimental carcinogenesis which show a greater number of tumors in animals fed high-fat or high-calorie diets. Increased fiber intake appears to offer some protection against colorectal cancer. Plausible mechanisms have been proposed in animals for the role of fat and fiber in colorectal carcinogenesis; the mechanisms in human populations await further description. The interrelationships between fat consumption and consumption of dietary fiber and micronutrients have made it difficult to assess the roles of these substances in the etiology of colorectal cancer. Calcium offers protection in animal systems, and the data in humans are suggestive but not yet conclusive. Data on the role of alcohol in colorectal carcinogenesis remain inconclusive. Little evidence exists for a protective effect of retinoids and carotenoids; the evidence for selenium and vitamin C is limited and evolving.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2537285

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  13 in total

1.  Consensus on prevention and treatment of colorectal cancer: implications for general practice.

Authors:  M Lloyd
Journal:  Br J Gen Pract       Date:  1990-12       Impact factor: 5.386

2.  Evaluation of the Impact of Cancer Treatment on the Adoption and Consolidation of Pro-Health Attitudes in the Field of Cancer in Treated Patients with Colon Cancer.

Authors:  Krzysztof Adamowicz; Renata Zaucha
Journal:  J Cancer Educ       Date:  2018-04       Impact factor: 2.037

3.  Hypertriglyceridemia is positively correlated with the development of colorectal tubular adenoma in Japanese men.

Authors:  Masafumi Tabuchi; Joji Kitayama; Hirokazu Nagawa
Journal:  World J Gastroenterol       Date:  2006-02-28       Impact factor: 5.742

4.  Gene expression profiles of colonic mucosa in healthy young adult and senior dogs.

Authors:  Dong Yong Kil; Brittany M Vester Boler; Carolyn J Apanavicius; Lawrence B Schook; Kelly S Swanson
Journal:  PLoS One       Date:  2010-09-22       Impact factor: 3.240

5.  Colon cancer incidence: recent trends in the United States.

Authors:  W H Chow; S S Devesa; W J Blot
Journal:  Cancer Causes Control       Date:  1991-11       Impact factor: 2.506

6.  [Modification of fecal bile acid excretion by fish oil in healthy probands].

Authors:  H P Bartram; A Gostner; W Scheppach; E Kelber; G Dusel; F Keller; H Kasper
Journal:  Z Ernahrungswiss       Date:  1995-09

Review 7.  Epidemiology of large bowel cancer.

Authors:  K E Levin; R R Dozois
Journal:  World J Surg       Date:  1991 Sep-Oct       Impact factor: 3.352

8.  Effect of gastroduodenal juice and dietary fat on the development of Barrett's esophagus and esophageal neoplasia: an experimental rat model.

Authors:  G W Clark; T C Smyrk; S S Mirvish; M Anselmino; Y Yamashita; R A Hinder; T R DeMeester; D F Birt
Journal:  Ann Surg Oncol       Date:  1994-05       Impact factor: 5.344

9.  A synergistic antiproliferation effect of curcumin and docosahexaenoic acid in SK-BR-3 breast cancer cells: unique signaling not explained by the effects of either compound alone.

Authors:  Jeffrey D Altenburg; Andrew A Bieberich; Colin Terry; Kevin A Harvey; Justin F Vanhorn; Zhidong Xu; V Jo Davisson; Rafat A Siddiqui
Journal:  BMC Cancer       Date:  2011-04-21       Impact factor: 4.430

10.  Anticancer properties of propofol-docosahexaenoate and propofol-eicosapentaenoate on breast cancer cells.

Authors:  Rafat A Siddiqui; Mustapha Zerouga; Min Wu; Alicia Castillo; Kevin Harvey; Gary P Zaloga; William Stillwell
Journal:  Breast Cancer Res       Date:  2005-06-07       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.